dimarts, 21 de febrer del 2017

CareFusion expands Alaris warning

CareFusion expands Alaris warningThe U.K.’s Medicines & Healthcare Products Regulatory Agency issued an 2nd warning for CareFusion’s Alaris drug pump after the company discovered that the Alaris pumps with broken springs in the plunger assembly could accidentally release a single dose of medication.

The UK watchdog 1st warned customers in December last year that the pump could release a dose of medication if it was used with non-recommended syringes.

“Since we published MDA/2016/023, the manufacturer has identified the potential for a broken spring in the plunger assembly to cause an unintended movement of the syringe plunger, which may result in a bolus of up to 0.5ml. This problem may be significant in the treatment of paediatric patients,” the group wrote. “This issue may affect all syringes (recommended and non-recommended) when used in the specified Alaris syringe pumps.”

Get the full story at our sister site, Drug Delivery Business News.

The post CareFusion expands Alaris warning appeared first on MassDevice.



from MassDevice http://ift.tt/2mijsHL

Cap comentari:

Publica un comentari a l'entrada